CONSUN PHARMA(01681.HK): Upsizes Share Repurchase Plan, Proposing to Deploy a Total of Up to HK$300 Million

NewTimeSpace · 2026/01/29 17:09 · By Zeyu Wu

NewTimeSpace News,CONSUN PHARMA announced an upsized share repurchase plan via a 公告 on January 29. Based on the repurchase mandate previously granted by shareholders, the company will add a maximum of HK$100 million to the existing repurchase fund of no more than HK$200 million, with a total proposed fund deployment of up to HK$300 million for timely share repurchases on the open market.

NewTimeSpace News: CONSUN PHARMA(01681.HK) released a voluntary announcement on January 29, 2026, disclosing the latest progress of its share repurchase plan. According to the announcement, on June 13, 2025, the board of directors had resolved to allocate no more than HK$200 million for the repurchase plan; on January 29, 2026, the board further resolved to upsize the plan by adding a maximum of HK$100 million in repurchase funds, bringing the total proposed fund deployment to no more than HK$300 million.

CONSUN PHARMA stated that the repurchase is based on confidence in the company’s business development and prospects, believing that the current stock price does not fully reflect its intrinsic value and long-term growth potential. The repurchase will optimize the capital structure, enhance net asset value per share and earnings per share, and is in the overall interests of the company and its shareholders.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.

Tags：

CONSUN PHARMA 01681.HK